BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+2.31%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$3.71B
AUM Growth
+$3.71B
Cap. Flow
+$214M
Cap. Flow %
5.78%
Top 10 Hldgs %
63.73%
Holding
72
New
5
Increased
7
Reduced
10
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CDTX icon
51
Cidara Therapeutics
CDTX
$1.61B
$6.46M 0.17%
6,861,127
PVLA
52
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$6.14M 0.17%
20,609,863
ELDN icon
53
Eledon Pharmaceuticals
ELDN
$155M
$5.93M 0.16%
4,326,710
NLSP icon
54
NLS Pharmaceutics
NLSP
$9.96M
$3.97M 0.11%
5,747,126
DCTH icon
55
Delcath Systems
DCTH
$381M
$3.95M 0.11%
976,149
-202,638
-17% -$821K
KRON
56
DELISTED
Kronos Bio
KRON
$3.78M 0.1%
2,905,043
+91,558
+3% +$119K
VIRX
57
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.76M 0.1%
3,614,662
MTEM
58
DELISTED
Molecular Templates, Inc.
MTEM
$3.36M 0.09%
532,038
-4,464,527
-89% +$1.26M
RAIN
59
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$3.04M 0.08%
3,526,729
UNCY icon
60
Unicycive Therapeutics
UNCY
$75.8M
$2.94M 0.08%
+3,413,563
New +$2.94M
IVA
61
Inventiva
IVA
$802M
$2.88M 0.08%
686,040
CRVS icon
62
Corvus Pharmaceuticals
CRVS
$419M
$2M 0.05%
1,370,947
FBRX icon
63
Forte Biosciences
FBRX
$138M
$1.97M 0.05%
+2,982,105
New +$1.97M
ASLN
64
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.94M 0.05%
1,049,999
MOLN
65
Molecular Partners
MOLN
$139M
$1.77M 0.05%
443,221
IMUX icon
66
Immunic
IMUX
$79.4M
$1.69M 0.05%
1,149,425
ELEV
67
DELISTED
Elevation Oncology
ELEV
$1.53M 0.04%
2,312,200
RZLT icon
68
Rezolute
RZLT
$630M
$252K 0.01%
190,815
NEUP
69
Neuphoria Therapeutics Inc. Common Stock
NEUP
$24.4M
$128K ﹤0.01%
47,372
-33,599
-41% -$90.7K
INFI
70
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-6,353,645
Closed -$1.34M
ARAV
71
DELISTED
Aravive, Inc. Common Stock
ARAV
-4,784,214
Closed -$6.03M
GLMD icon
72
Galmed Pharmaceuticals
GLMD
$7.07M
-89,853
Closed -$261K